First-Line Extensive-Stage Small Cell Lung Cancer: Examining the New Role of Combination Chemotherapy and Immunotherapy

Article

Join us to learn more about how to navigate the new role of immunotherapy in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer on Wednesday, October 28, 2020 at 8:00 PM EDT.

First-Line Extensive-Stage Small Cell Lung Cancer:
Examining the New Role of Combination Chemotherapy and Immunotherapy

Date: Wednesday, October 28, 2020
Time: 8:00 PM EDT

Register today
Join an expert panel in thoracic oncology featuring; Kathryn Gold, MD, Taofeek Owonikoko, MD, Taofeek Owonikoko, MD, Konstantinos Leventakos, M.D., Ph.D. as they discuss how to navigate the new role of I/O therapy in combination with chemotherapy for the first-line treatment of ES-SCLC and questions surrounding how to use this approach in clinical practice.

Attend this special event to have a better understanding of:

  • Characteristics of small cell lung cancer
  • How SCLC and NSCLC are differentiated in clinical practice
  • The need for rapid treatment response to ES-SCLC
  • The role of combination chemotherapy + I/O therapy in first-line ES-SCLC
  • Clinical trials for IO + chemotherapy combinations
    Standard first-line approach
  • Patient involvement in treatment​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​


    Moderator:

Kathryn Gold, MD
Associate Professor and Vice Chief
Division of Hematology and Oncology
UC San Diego Moores Cancer Cancer
San Diego, California

Panelists:

Taofeek Owonikoko, MD
Professor and Vice Chair for Faculty Development
Hematology and Medical Oncology
Emory University
Atlanta, GA

Konstantinos Leventakos, M.D., Ph.D.
Oncologist
Mayo Clinic
Rochester, MN
Sponsored By:

Related Videos
Jobelle Baldonado, MD
Joshua K. Sabari, MD, an expert on lung cancer, presenting slides
Chul Kim, MD, MPH
Salman R. Punekar, MD, Mayo Clinic
Federico Cappuzzo, MD
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Edgardo S. Santos Castillero, MD, FACP
Joshua K. Sabari, MD